DUBLIN–(BUSINESS WIRE)–The “Nuvigil
– API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.
Nuvigil – API Insight, 2019 provides product and API
manufacturers’ details across the globe along with the location. The
report gives the clear idea on the country wise DMF filed by worldwide
companies related to Nuvigil. The report also highlights the patent
details of Nuvigil.
Scope of the Report
-
A comprehensive product overview including product description,
regulatory milestones, safety, pharmacological properties, clinical
trials, and product development activities have been elaborated in
this report -
Patent information around Nuvigil in United States (US) and Europe
(EU) has been highlighted - API manufacturers for Nuvigil in United States, Europe, China and India
-
The report contains historical and forecasted sales for Nuvigil till
2021 -
Enlists the market competition and emerging therapies in the space
where Nuvigil operates
Reasons to Buy
-
Evaluate the marketing status of Nuvigil to exploit opportunities for
generic Nuvigil development opportunities -
Design effective counter-strategies to gain competitive advantage by
identifying the key patent expiry details with respect to Nuvigil -
API intelligence over Nuvigil and gaining primary intelligence over
Active Ingredient manufacturers by country -
Make more informed business decisions from insightful and in-depth
analysis of the Nuvigil’s performance
Key Topics Covered
1. Nuvigil Overview
2. Nuvigil Global Sales Assessment
- Nuvigil Historical Global Sales
- Nuvigil Forecasted Global Sales
3. Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
4. Product Details by country
5. Patent Information
6. Global API Manufacturers Assessment
- Active Pharmaceutical Ingredient (API) Manufacturers by Country
- Active Pharmaceutical Ingredient (API) Manufacturers by Region
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/7uwhs4
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Central
Nervous System Drugs